Explore our
Portfolio of Niche Generic and Differentiated Finished Formulations for Human Health
Brivacetam Oral Solution
| Therapeutic category | Anticonvlusant |
| Product Name/Dosage form/Strength | Brivaracetam Oral Solution |
| Commercialization Support for regulated market | Supply form USFDA or EU GMP approved facility |
Scindazole Oral granules
| Therapeutic category | Antimicrobial |
| Product Name/Dosage form/Strength | Scinadazole Oral Granules/2g per packet |
| Commercialization Support for regulated market | Supply form USFDA or EU GMP approved facility |
PEG 3350 Oral granules
| Therapeutic category | Laxative |
| Product Name/Dosage form/Strength | ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE |
| Commercialization Support for regulated market | Supply form USFDA or EU GMP approved facility |
Nimodipine Oral solution
| Therapeutic category | Calcium Channel Blocker |
| Product Name/Dosage form/Strength | Nimodipine Oral Solution 6mg/ml |
| Commercialization Support for regulated market | Supply form USFDA or EU GMP approved facility |
L‑Glutamine Oral solution
| Therapeutic category | Amino Acid |
| Product Name/Dosage form/Strength | L-Glutamine Oral Solution 5gm per packet |
| Commercialization Support for regulated market | Supply form USFDA or EU GMP approved facility |
Eltrombopag Powder
| Therapeutic category | Amino Acid |
| Regulated market –Â Stage and Next steps | Lab Scale Development completed (US & EU); Technology Transfer |
| Commercialization Support for regulated market | Supply form USFDA or EU GMP approved facility |
